Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.

INTRODUCTION AND HYPOTHESIS: The vaginal pessary is a conservative method for treating pelvic organ prolapse (POP). It is able to reduce symptoms with minimal complications, improving quality of life (QOL). This study's hypothesis was that the use of pessaries decreases quantitative measures and improves women's QOL. We aimed to evaluate the effects of the use of a ring pessary on the quantitative measurements of POP by the Pelvic Organ Prolapse Quantification (POP-Q) and on QOL. METHODS: Prospective cohort study divided in two stages. In stage I POP-Q and QOL were assessed prior to the use of the ring pessary and in stage II after its use for at least 4 months with pessary removal 72 h before clinical evaluation. Wilcoxon tests were performed for necessary comparisons and Spearman's tests for calculating correlations. RESULTS: One hundred thirty-six women were evaluated, of which 50 were included. There was a decrease in POP in at least one of the vaginal compartments in the women included. When assessing individual measures (Ba, Bp and C), reductions in all measures were observed. There was also an improvement in the general and specific quality of life of women. CONCLUSION: The ring pessary proved to be a good therapeutic option, with a reduction in POP-Q measurements and/or absence of POP progression in the short term and an improvement in women's QOL.

Pelvic floor muscle function and quality of life in postmenopausal women with and without pelvic floor dysfunction.

INTRODUCTION: This study aims to compare pelvic floor muscle (PFM) function in postmenopausal women with and without pelvic floor dysfunction (PFD) and the relation between PFM function and quality of life. MATERIAL AND METHODS: A case-control study with 216 postmenopausal women with (n = 126) and without (n = 90) PFD. PFM function was assessed by digital vaginal palpation using the PERFECT scale. Specific quality of life was evaluated using the King's Health Questionnaire for women with urinary incontinence and the Prolapse Quality-of-Life Questionnaire for women with pelvic organ prolapse. We analyzed women with PFD into two categories: Oxford's grade ≤2 or ≥3 using a chi-squared test. RESULTS: Out of 126 womem with PFD 44 (34.9%) presented stress urinary incontinence, 21 (16.6%) had pelvic organ prolapse and 61 (48.4%) had urinary incontinence + pelvic organ prolapse. Strength had a median value 2 (0-5) in all women studied and most of them had insufficient strength, reduced endurance and repetition without statistical difference between groups. Incontinent women with strength ≤2 had worse perception of general health domain of King's Health Questionnaire (p = 0.007). No association was found between PFM function and Prolapse Quality-of-Life Questionnaire. CONCLUSIONS: PFM function assessed by bidigital palpation in postmenopausal women was not sufficiently sensitive to differentiate between women with vs. women without PFM dysfunction and was not related with specific quality of life in women with urinary incontinence and pelvic organ prolapse, respectively. These data should be used to reinforce the widespread recommendation that PFM training is essencial in PFD treatment.

Clinical impact of bowel symptoms in women with pelvic floor disorders.

INTRODUCTION AND HYPOTHESIS: The aim of this study was to evaluate the correlations between the POP-Q Bp point and the perineal body (Pb) and genital hiatus (Gh) measurements and constipation, anal incontinence, severity of symptoms and quality of life. METHODS: The patients were distributed into two groups according to the posterior vaginal wall Bp point: one group with Bp ≤-1 (without posterior vaginal wall prolapse, control group) and the other group with Bp ≥0 (with posterior vaginal wall prolapse, case group). Demographic data, defecatory dysfunction and SF-36 scores were compared between the groups. Correlations between severity of posterior prolapse (Bp, Gh, Pb and Gh + Pb) and severity of bowel symptoms were also calculated. RESULTS: A total of 613 women were evaluated, of whom 174 were included, 69 (39.7%) in the control group and 105 (60.3%) in the case group. The groups were similar in terms of anal incontinence, fecal urgency and/or constipation. There was no correlation between the severity of constipation and anal incontinence according to the Wexner score, and the severity of posterior vaginal wall prolapse measured in terms of point Bp. There were, however, statistically significant differences in Pb, Gh and Gh + Pb between the groups. The Pb and Gh + Pb measurements were positively correlated with symptoms of constipation, as well as with the scores of some SF-36 domains, but were not correlated with anal incontinence. CONCLUSIONS: These results suggest that the severity of posterior vaginal wall prolapse is not correlated with constipation or anal incontinence, but Pb and Gh + Pb measurements are correlated with constipation and SF-36 scores.

Prevalence of unreported bowel symptoms in women with pelvic floor dysfunction and the impact on their quality of life.

INTRODUCTION AND HYPOTHESIS: Little information is available on the recurrent coexistence of pelvic organ prolapse (POP), urinary (UI) and/or anal (AI) incontinence and defecatory dysfunctions and the relationship between these disorders. The purpose of this study is to report the prevalence, bother, and impact on quality of life (QoL) of unreported bowel symptoms in women presenting to a Brazilian tertiary urogynecology clinic. METHODS: The study was a cross-section survey of 172 patients with symptoms of pelvic floor disorders (PFD). Patients who reported any defecatory and/or continence disorders were included in the study group, and the others were included in the control group. Patients with UI were also compared with those with double incontinence (DI): AI and UI. Univariate analysis was conducted using the Mann-Whitney U test for continuous nonparametric data. RESULTS: After the interview, 54.6 % (n = 94) of patients presented AI and/or defecatory disorders: 67.0 % constipation, 41.4 % AI, and 34.0 % fecal urgency. Women from the study group scored worse in the QoL questionnaires compared with women from the control group. Among women with UI, 23.21 % had associated AI. Women with DI scored worse in the QoL questionnaires. CONCLUSION: Anal and urinary dysfunctions are usually associated and have a great impact on a woman's QoL. An integrated approach across specialties should lead to improved patient care. Therefore, our study is relevant because it emphasizes the importance of urogynecologists routinely investigating such symptoms. To do so, standardized questionnaires should be included in the evaluation of all these patients.

Pelvic floor ultrasound finds after episiotomy and severe perineal tear: systematic review and meta-analysis.

AIM: Vaginal delivery is a well-known risk factor for pelvic floor muscle (PFM) injuries, mainly when associated to prolonged labor, instrumental birth and perineal trauma such as episiotomy and perineal tears. The purpose of this meta-analysis was to test the hypothesis that episiotomy and severe perineal tear may increase the risk of pelvic floor damage. METHODS: We performed a systematic literature search through electronic databases including MEDLINE via PubMed, LILACS via BVS, Embase via Elsevier and Cochrane Library up to January 2019. We included articles that reported as outcome one or more morphological aspects of the PFM evaluated by ultrasonography in primiparous women three to 24 months postpartum. This review is registered in the PROSPERO database (registration number: CRD42017075750). RESULTS: the final selection was composed of 18 articles for the systematic review, and 10 for the meta-analysis. Women with levator ani muscle (LAM) avulsion were 1.77 times more likely to have undergone episiotomy (OR = 1.77, CI 95% 1.25-2.51, five trials), 4.31 times more likely to have severe perineal tear (OR = 4.31, CI 95% 2.34-7.91, two trials). Women with defects in the anal sphincters were 2.82 times more likely to have suffered severe perineal tear (OR = 2.82, 95% CI 1.71-4.67, three trials). CONCLUSIONS: Both episiotomy and severe perineal tear are risk factors for LAM avulsion and anal sphincter injury, and this can be useful for identifying women who are at greater risk of developing PFM dysfunctions.

Quality of Life in Women with Defecatory Dysfunctions: Systematic Review of Questionnaires Validated in the Portuguese Language.

OBJECTIVE: To identify the quality of life (QoL) assessment instruments related to the health of women with fecal incontinence (FI) or anal incontinence (AI). DATA SOURCES: Systematic review conducted in the Virtual Health Library (VHL), PubMed and Cochrane Library databases. The descriptors used were: Questionnaire, Questionnaires, Quality of life, validation, validation Studies, anal incontinence, fecal incontinence and constipation. The search was performed between December 26, 2017 and the beginning of January 2018. The limits used were female gender. SELECTION OF STUDIES: Initially, 5,143 articles were obtained in the search. The articles of validation for Portuguese of questionnaires for the evaluation of the impact of FI/AI on the QoL of women were considered eligible. DATA COLLECTION: The article search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines. DATA SYNTHESIS: Of the 5,143 articles, only 2 fulfilled the inclusion and exclusion criteria: Fecal Incontinence Quality of Life (FIQL) and the Wexner scale (WS). The FIQL evaluates the QoL related to FI, not covering flatus incontinence. The WS assesses flatus incontinence and the severity of the AI. The WS obtained an interclass correlation coefficient (ICC) of 0.932 and a Cronbach α coefficient > 0.90. The FIQL obtained intraexaminer and interexaminer reproducibility ranging from 0.929 to 0.957 and from 0.944 to 0.969, respectively. CONCLUSIONS: The WS and the FIQL have satisfactory reliability and validity for use during gynecological consultations.

OBJETIVO: Identificar os instrumentos de avaliação da qualidade de vida (QV) relacionados à saúde de mulheres com incontinência fecal (IF) ou incontinência anal (IA). FONTES DOS DADOS: Revisão sistemática nas bases de dados da BVS, PubMed e Biblioteca Cochrane. Os descritores usados foram: Questionnaire, Questionnaires, Quality of life, validation, validation Studies, anal incontinence, fecal incontinence e constipation. A pesquisa foi realizada entre 26 de dezembro de 2017 até o início de janeiro de 2018. Os limites utilizados foram sexo feminino. SELEçãO DOS ESTUDOS: Inicialmente, 5.143 artigos foram obtidos na pesquisa. Os artigos de validação para o português de questionários de avaliação do impacto da IF/IA na QV das mulheres foram considerados elegíveis. COLETA DE DADOS: A busca de artigos foi conduzida de acordo com as diretrizes do Principais Itens para Relatar Revisões Sistemáticas e Meta-análises (PRISMA, na sigla em inglês). SíNTESES DOS DADOS: Dos 5.143 artigos, apenas 2 preencheram os critérios de inclusão e exclusão: Qualidade de Vida em Incontinência Fecal (FIQL, na sigla em inglês) e Escala de Wexner (WS, na sigla em inglês). O FIQL avalia a QV relacionada à FI, não abrangendo a incontinência de gases. O WS avalia a incontinência dos flatos e a gravidade da IA. O WS obteve um coeficiente de correlação interclasse (ICC, na sigla em inglês) de 0,932 e alfa de Cronbach > 0,90. O FIQL obteve reprodutibilidade intraexaminador e interexaminador variando de 0,929 a 0,957 e de 0,944 a 0,969, respectivamente. CONCLUSõES: O WS e o FIQL têm confiabilidade e validade satisfatória para uso durante consultas ginecológicas.

Sexual function of undergraduate women: a comparative study between Brazil and Italy.

OBJECTIVE: to evaluate the sexual function of Italian and Brazilian nursing students using the Female Sexual Function Index (FSFI), to estimate the prevalence of sexual dysfunctions and related factors. METHOD: this is a cross-sectional study involving 84 Brazilian and 128 Italian undergraduate. For the evaluation of sexual function, the Female Sexual Function Index (FSFI) questionnaire was used. RESULTS: Italian women presented significantly higher sexual dysfunction index (n=78/60.9%) than the Brazilian women (n=32/38.1%) (p=0.00). Only the "desire" and "excitation" domains showed no difference between groups. Younger, single and without a steady relationship women had a higher rate of sexual dysfunction (p<0.05). CONCLUSION: the high rate of sexual dysfunction in a young public suggests the need for more research to increase knowledge about the influence of psychosocial and related factors on female sexual function, directing care towards the promotion of sexual and reproductive health.

Costs and mortality rates of surgical approaches to hysterectomy in Brazil.

OBJECTIVE: To analyze the costs of hysterectomies performed in Brazil due to benign conditions, and to assess its hospital admittance and mortality rates. METHODS: A retrospective cohort was carried out from January 2010 to December 2014, analyzing all hysterectomies (n = 428,346) registered on the DATASUS database between January 2010 and December 2014. Data were collected through a structured questionnaire and analyzed using the SPSS 20.0 for Windows. RESULTS: Hospital admissions were 300,231 for total abdominal hysterectomies, 46,056 for vaginal hysterectomies, 29,959 for subtotal abdominal hysterectomies and 1,522 for laparoscopic hysterectomies. Mortality rates were 0.26%, 0.09%, 0.07% and 0.05% for subtotal, total abdominal, laparoscopic, and vaginal hysterectomies, respectively. Among the procedures studied, total abdominal hysterectomies had the most costs (R$217,802,574.77), followed by vaginal hysterectomies (R$24,173,490.00), subtotal abdominal hysterectomies (R$19.253.300,00) and laparoscopic hysterectomies (R$794,680.40). CONCLUSIONS: Total abdominal hysterectomies had the highest overall costs mainly because it was the most commonly performed technique. Mortality rates were greatest in subtotal abdominal hysterectomies; this, however, may be due to bias related to missing data in our database.

Defecatory dysfunction and fecal incontinence in women with or without posterior vaginal wall prolapse as measured by pelvic organ prolapse quantification (POP-Q).

INTRODUCTION AND HYPOTHESIS: Pelvic Floor Dysfunction is a complex condition that may be asymptomatic or may involve a loto f symptoms. This study evaluates defecatory dysfunction, fecal incontinence, and quality of life in relation to presence of posterior vaginal prolapse. METHODS: 265 patients were divided into two groups according to posterior POP-Q stage: posterior POP-Q stage ≥2 and posterior POP-Q stage <2. The two groups were compared regarding demographic and clinical data; overall POP-Q stage, percentage of patients with defecatory dysfunction, percentage of patients with fecal incontinence, pelvic floor muscle strength, and quality of life scores. The correlation between severity of the prolapse and severity of constipation was calculated using ρ de Spearman (rho). RESULTS: Women with Bp stage ≥2 were significantly older and had significantly higher BMI, numbers of pregnancies and births, and overall POP-Q stage than women with stage <2. No significant differences between the groups were observed regarding proportion of patients with defecatory dysfunction or incontinence, pelvic floor muscle strength, quality of life (ICIQ-SF), or sexual impact (PISQ-12). POP-Q stage did not correlate with severity of constipation and incontinence. General quality of life perception on the SF-36 was significantly worse in patients with POP-Q stage ≥2 than in those with POP-Q stage <2. CONCLUSIONS: The lack of a clinically important association between the presence of posterior vaginal prolapse and symptoms of constipation or anal incontinence leads us to agree with the conclusion that posterior vaginal prolapse probably is not an independent cause defecatory dysfunction or fecal incontinence.

Quality of life in women with defecatory dysfunctions: systematic review of questionnaires validated in the portuguese language / Qualidade de vida em mulheres com disfunções defecatórias: revisão sistemática de questionários validados para a língua portuguesa

Abstract Objective To identify the quality of life (QoL) assessment instruments related to the health of women with fecal incontinence (FI) or anal incontinence (AI). Data Sources Systematic review conducted in the Virtual Health Library (VHL), PubMed and Cochrane Library databases. The descriptors used were: Questionnaire, Questionnaires, Quality of life, validation, validation Studies, anal incontinence, fecal incontinence and constipation. The search was performed between December 26, 2017 and the beginning of January 2018. The limits used were female gender. Selection of Studies Initially, 5,143 articles were obtained in the search. The articles of validation for Portuguese of questionnaires for the evaluation of the impact of FI/AI on the QoL of women were considered eligible. Data Collection The article search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines. Data Synthesis Of the 5,143 articles, only 2 fulfilled the inclusion and exclusion criteria: Fecal Incontinence Quality of Life (FIQL) and the Wexner scale (WS). The FIQL evaluates the QoL related to FI, not covering flatus incontinence. The WS assesses flatus incontinence and the severity of the AI. The WS obtained an interclass correlation coefficient (ICC) of 0.932 and a Cronbach α coefficient > 0.90. The FIQL obtained intraexaminer and interexaminer reproducibility ranging from 0.929 to 0.957 and from 0.944 to 0.969, respectively. Conclusions The WS and the FIQL have satisfactory reliability and validity for use during gynecological consultations.

Resumo Objetivo Identificar os instrumentos de avaliação da qualidade de vida (QV) relacionados à saúde de mulheres com incontinência fecal (IF) ou incontinência anal (IA). Fontes dos dados Revisão sistemática nas bases de dados da BVS, PubMed e Biblioteca Cochrane. Os descritores usados foram: Questionnaire, Questionnaires, Quality of life, validation, validation Studies, anal incontinence, fecal incontinence e constipation. A pesquisa foi realizada entre 26 de dezembro de 2017 até o início de janeiro de 2018. Os limites utilizados foram sexo feminino. Seleção dos estudos Inicialmente, 5.143 artigos foram obtidos na pesquisa. Os artigos de validação para o português de questionários de avaliação do impacto da IF/IA na QV das mulheres foram considerados elegíveis. Coleta de dados A busca de artigos foi conduzida de acordo com as diretrizes do Principais Itens para Relatar Revisões Sistemáticas e Meta-análises (PRISMA, na sigla em inglês). Sínteses dos dados Dos 5.143 artigos, apenas 2 preencheram os critérios de inclusão e exclusão: Qualidade de Vida em Incontinência Fecal (FIQL, na sigla em inglês) e Escala de Wexner (WS, na sigla em inglês). O FIQL avalia a QV relacionada à FI, não abrangendo a incontinência de gases. O WS avalia a incontinência dos flatos e a gravidade da IA. O WS obteve um coeficiente de correlação interclasse (ICC, na sigla em inglês) de 0,932 e alfa de Cronbach > 0,90. O FIQL obteve reprodutibilidade intraexaminador e interexaminador variando de 0,929 a 0,957 e de 0,944 a 0,969, respectivamente. Conclusões O WS e o FIQL têm confiabilidade e validade satisfatória para uso durante consultas ginecológicas.

Sexual function of undergraduate women: a comparative study between Brazil and Italy / La función sexual de universitarias: estudio comparativo entre Brasil e Italia / Função sexual de universitárias: estudo comparativo entre Brasil e Itália

ABSTRACT Objective: to evaluate the sexual function of Italian and Brazilian nursing students using the Female Sexual Function Index (FSFI), to estimate the prevalence of sexual dysfunctions and related factors. Method: this is a cross-sectional study involving 84 Brazilian and 128 Italian undergraduate. For the evaluation of sexual function, the Female Sexual Function Index (FSFI) questionnaire was used. Results: Italian women presented significantly higher sexual dysfunction index (n=78/60.9%) than the Brazilian women (n=32/38.1%) (p=0.00). Only the "desire" and "excitation" domains showed no difference between groups. Younger, single and without a steady relationship women had a higher rate of sexual dysfunction (p<0.05). Conclusion: the high rate of sexual dysfunction in a young public suggests the need for more research to increase knowledge about the influence of psychosocial and related factors on female sexual function, directing care towards the promotion of sexual and reproductive health.

RESUMEN Objetivo: evaluar la función sexual de académicas italianas y brasileñas de enfermería utilizando el Female Sexual Function Index (FSFI), estimar el predominio de las disfunciones sexuales y los factores relacionados. Método: estudio transversal, de lo cual participaron 212 universitarias, siendo 84 brasileñas y 128 italianas. Para evaluar la función sexual, se utilizó el cuestionario Female Sexual Function Index(FSFI). Resultados: Las italianas presentaron índice de disfunción sexual significativamente superior (n=78/60,9%) en comparación con el de las brasileñas (n=32/38,1%) (p=0,00). Sólo los dominios "deseo" y "excitación" no presentaron diferencia entre los grupos. Las mujeres más jóvenes, solteras y sin relación estable presentaron un índice de disfunción sexual más alto (p<0,05). Conclusión: el elevado índice de disfunción sexual en un público tan joven sugiere la necesidad de realizar más investigaciones que incrementen el conocimiento sobre la influencia de los factores psicosociales y relacionales en la función sexual femenina, dirigiendo el cuidado para la promoción de la salud sexual y reproductiva.

RESUMO Objetivo: avaliar a função sexual de acadêmicas de enfermagem italianas e brasileiras utilizando o Female Sexual Function Index (FSFI), estimar a prevalência das disfunções sexuais e os fatores relacionados. Método: estudo transversal, o qual participaram 212 universitárias, sendo 84 brasileiras e 128 italianas. Para a avaliação da função sexual, empregou-se o questionário Female Sexual Function Index (FSFI). Resultados: As italianas apresentaram índice de disfunção sexual significativamente superior (n=78/60,9%) do que as brasileiras (n=32/38,1%) (p=0,00). Apenas os domínios "desejo" e "excitação" não apresentaram diferença entre os grupos. As mulheres mais jovens, solteiras e sem relacionamento estável apresentaram índice de disfunção sexual maior (p<0,05). Conclusão: o elevado índice de disfunção sexual em um público tão jovem sugere a necessidade da realização de mais investigações que incrementem o conhecimento sobre a influência dos fatores psicossociais e relacionais na função sexual feminina, direcionando o cuidado para a promoção da saúde sexual e reprodutiva.

Costs and mortality rates of surgical approaches to hysterectomy in Brazil

ABSTRACT OBJECTIVE To analyze the costs of hysterectomies performed in Brazil due to benign conditions, and to assess its hospital admittance and mortality rates. METHODS A retrospective cohort was carried out from January 2010 to December 2014, analyzing all hysterectomies (n = 428,346) registered on the DATASUS database between January 2010 and December 2014. Data were collected through a structured questionnaire and analyzed using the SPSS 20.0 for Windows. RESULTS Hospital admissions were 300,231 for total abdominal hysterectomies, 46,056 for vaginal hysterectomies, 29,959 for subtotal abdominal hysterectomies and 1,522 for laparoscopic hysterectomies. Mortality rates were 0.26%, 0.09%, 0.07% and 0.05% for subtotal, total abdominal, laparoscopic, and vaginal hysterectomies, respectively. Among the procedures studied, total abdominal hysterectomies had the most costs (R$217,802,574.77), followed by vaginal hysterectomies (R$24,173,490.00), subtotal abdominal hysterectomies (R$19.253.300,00) and laparoscopic hysterectomies (R$794,680.40). CONCLUSIONS Total abdominal hysterectomies had the highest overall costs mainly because it was the most commonly performed technique. Mortality rates were greatest in subtotal abdominal hysterectomies; this, however, may be due to bias related to missing data in our database.

Síndrome pré-menstrual e síndrome disfórica pré-menstrual: aspectos atuais / Premenstrual syndrome and premenstrual dysphoric syndrome: current aspects

A síndrome pré-menstrual (SPM) caracteriza-se por um conjunto de sintomas físicos, emocionais e comportamentais, cíclicos e recorrentes que iniciam na semana anterior à menstruação e aliviam com o início do fluxo, sendo um distúrbio altamente prevalente entre as mulheres em idade fértil. Enquetes epidemiológicas mostram que 75 a 80% das mulheres apresentam sintomas durante o período pré-menstrual. A revisão de literatura, entretanto, mostrou que o assunto está longe de um consenso, com controvérsias sobre fatores de risco, proteção e tratamento. Uma vez confirmado o diagnóstico, modificações no estilo de vida, suplemento de cálcio, vitamina B12 e V. agnus castus são opções não-farmacológicas razoáveis. Os inibidores seletivos de recaptação da serotonina (ISRS) são atualmente considerados a classe farmacológica mais efetiva. Outra opção é o uso de anticoncepcionais orais (ACO) combinados com etinilestradiol (EE) e drospirenona que foram aprovados pela Food and Drug Administration (FDA) para o tratamento da SPM e do transtorno disfórico pré-menstrual (TDPM)

The premenstrual syndrome (PMS) is characterized by a set of physical symptoms, emotional and behavioral, cyclical and recurring that start in the week before menstruation and relieve the beginning of the stream, being a highly prevalent disorder among women of childbearing age. Epidemiological surveys show that 75 to 80% of women experience symptoms during the premenstrual period. The literature review, however, showed that the subject is far from a consensus, with controversies about risk factors, protection and treatment. Once the diagnosis is confirmed, changes in lifestyle, calcium supplement, vitamin B12 and V. agnus castus are pharmacologic reasonable options. The selective serotonin reuptake inhibitors (SSRIs) are currently considered the most effective pharmacological class. Another option is the use of oral contraceptive combined with drospirenone and ethinilestradiol (EE) which were approved by the Food and Drug Administration (FDA) for the treatment of PMS and premenstrual dysphoric disorder (PMDD)

Ruptura de hematoma subcapsular hepático como complicação da síndrome HELLP - revisão de literatura / Ruptured subcapsular hepatic haematoma as a HELLP syndrome complication - literature review

A síndrome HELLP caracteriza-se pela associação de plaquetopenia, aumento das enzimas hepáticas e presença de hemólise em paciente gestante. O acrônimo representa as iniciais das alterações laboratoriais (hemolysis; elevated liver enzimes; low platelets). Em menos de 2% das gestações complicadas por síndrome HELLP ocorre sangramento espontâneo severo do fígado (formação de hematoma subcapsular), acompanhado de necrose hemorrágica das células hepáticas e ruptura da cápsula de Glisson. Essas intercorrências têm evolução frequentemente fulminante, sendo que elevam a mortalidade materna para mais de 50%. Este artigo apresentou uma revisão de literatura sobre hematoma subcapsular hepático como complicação da síndrome HELLP, uma entidade clínica que, apesar de rara, exige suspeição clínica para diagnóstico rápido e manejo oportuno

HELLP syndrome is characterized by the association of thrombocytopenia, elevated liver enzymes and presence of hemolysis in a pregnant woman. The acronym stands for the initials of the laboratory abnormalities (hemolysis; elevated liver enzymes; low platelets). In less than 2% of pregnancies complicated by HELLP syndrome occurs spontaneous bleeding severe liver disease (formation of sub-capsular hematoma), accompanied by hemorrhagic necrosis of liver cells and rupture of the capsule of Glisson. These outcomes are often fulminant evolution, and maternal mortality amounted to more than 50%. This article presented a literature review on hepatic subcapsular haematoma as a complication of HELLP syndrome, a clinical entity, although rare requires clinical suspicion for a diagnosis of rapid and appropriate management